Lee, Z., Heston, W. D., Wang, X., & Basilion, J. P. (2023). GCP III is not the "off-target" for urea-based PSMA ligands. European Journal of Nuclear Medicine & Molecular Imaging, 50(10), 2944. https://doi.org/10.1007/s00259-023-06265-6
Chicago Style (17th ed.) CitationLee, Zhenghong, Warren D. Heston, Xinning Wang, and James P. Basilion. "GCP III Is Not the "Off-target" for Urea-based PSMA Ligands." European Journal of Nuclear Medicine & Molecular Imaging 50, no. 10 (2023): 2944. https://doi.org/10.1007/s00259-023-06265-6.
MLA (9th ed.) CitationLee, Zhenghong, et al. "GCP III Is Not the "Off-target" for Urea-based PSMA Ligands." European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 10, 2023, p. 2944, https://doi.org/10.1007/s00259-023-06265-6.